Table 2.
Tumor Biomarkers | OM Group | NOM Group | t-test | P value |
---|---|---|---|---|
ALP (U/L) | 108.25±10.39 | 94.73±1.89 | 1.281 | 0.209 |
Calcium (mmol/L) | 2.19±0.03 | 2.25±0.01 | −1.787 | 0.083 |
AFP (ng/mL) | 3.22±0.39 | 1.75±0.04 | 5.559 | <0.001 |
CEA (ng/mL) | 416.67±118.08 | 38.66±4.62 | 10.377 | <0.001 |
CA-125 (U/mL) | 378.63±78.31 | 64.39±4.22 | 9.930 | <0.001 |
CA-199 (U/mL) | 160.42±53.37 | 38.95±6.65 | 2.563 | 0.010 |
CA-153 (U/mL) | 54.99±10.63 | 19.32±0.75 | 6.483 | <0.001 |
CA-724 (U/mL) | 9.05±3.88 | 12.80±3.47 | −0.721 | 0.484 |
CYFRA21-1(ng/mL) | 29.28±4.16 | 9.37±0.75 | 4.714 | <0.001 |
TPSA (ng/L) | 4.59±0.45 | 1.63±0.10 | 6.420 | <0.001 |
NSE (μg/L) | 25.77±2.82 | 25.25±0.97 | 0.176 | 0.861 |
HB (g/L) | 108.34±3.55 | 117.41±0.47 | −2.529 | 0.017 |
Notes: Independent sample t-test. P < 0.05 denoted statistical significance.
Abbreviations: ALP, Alkaline phosphatase; OM, ocular metastasis; NOM, non-ocular metastasis; HB, hemoglobin.